7OR9

Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-222 and COVOX-278 Fabs

7OR9 の概要

• エントリーDOI: 10.2210/pdb7or9/pdb
• 分子名称: Spike protein S1, COVOX-222 Fab heavy chain, COVOX-222 Fab light chain, ... (10 entities in total)
• 機能のキーワード: sars-cov-2 b.1.1.7 variant, b.1.351 variant, p.1 variant, b.1.617 variant, antibody, receptor-binding-domain, spike, neutralisation, viral protein/immune system, viral protein
• 由来する生物種: Severe acute respiratory syndrome coronavirus 2 (2019-nCoV, SARS-CoV-2); 詳細
• タンパク質・核酸の鎖数: 5
• 化学式量合計: 118693.92

構造登録者

Zhou, D.,Ren, J.,Stuart, D.I. (登録日: 2021-06-04, 公開日: 2021-07-07, 最終更新日: 2024-11-13)

主引用文献

Liu, C.,Ginn, H.M.,Dejnirattisai, W.,Supasa, P.,Wang, B.,Tuekprakhon, A.,Nutalai, R.,Zhou, D.,Mentzer, A.J.,Zhao, Y.,Duyvesteyn, H.M.E.,Lopez-Camacho, C.,Slon-Campos, J.,Walter, T.S.,Skelly, D.,Johnson, S.A.,Ritter, T.G.,Mason, C.,Costa Clemens, S.A.,Gomes Naveca, F.,Nascimento, V.,Nascimento, F.,Fernandes da Costa, C.,Resende, P.C.,Pauvolid-Correa, A.,Siqueira, M.M.,Dold, C.,Temperton, N.,Dong, T.,Pollard, A.J.,Knight, J.C.,Crook, D.,Lambe, T.,Clutterbuck, E.,Bibi, S.,Flaxman, A.,Bittaye, M.,Belij-Rammerstorfer, S.,Gilbert, S.C.,Malik, T.,Carroll, M.W.,Klenerman, P.,Barnes, E.,Dunachie, S.J.,Baillie, V.,Serafin, N.,Ditse, Z.,Da Silva, K.,Paterson, N.G.,Williams, M.A.,Hall, D.R.,Madhi, S.,Nunes, M.C.,Goulder, P.,Fry, E.E.,Mongkolsapaya, J.,Ren, J.,Stuart, D.I.,Screaton, G.R.
Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum.
Cell, 184:4220-4236.e13, 2021

PubMed Abstract: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has undergone progressive change, with variants conferring advantage rapidly becoming dominant lineages, e.g., B.1.617. With apparent increased transmissibility, variant B.1.617.2 has contributed to the current wave of infection ravaging the Indian subcontinent and has been designated a variant of concern in the United Kingdom. Here we study the ability of monoclonal antibodies and convalescent and vaccine sera to neutralize B.1.617.1 and B.1.617.2, complement this with structural analyses of Fab/receptor binding domain (RBD) complexes, and map the antigenic space of current variants. Neutralization of both viruses is reduced compared with ancestral Wuhan-related strains, but there is no evidence of widespread antibody escape as seen with B.1.351. However, B.1.351 and P.1 sera showed markedly more reduction in neutralization of B.1.617.2, suggesting that individuals infected previously by these variants may be more susceptible to reinfection by B.1.617.2. This observation provides important new insights for immunization policy with future variant vaccines in non-immune populations.

PubMed: 34242578
DOI: 10.1016/j.cell.2021.06.020

実験手法

X-RAY DIFFRACTION (2.34 Å)